Precision Medicine and Progress in the Treatment of Hutchinson-Gilford Progeria Syndrome
- PMID: 29710145
- PMCID: PMC6368062
- DOI: 10.1001/jama.2018.2199
Precision Medicine and Progress in the Treatment of Hutchinson-Gilford Progeria Syndrome
Conflict of interest statement
Comment on
-
Association of Lonafarnib Treatment vs No Treatment With Mortality Rate in Patients With Hutchinson-Gilford Progeria Syndrome.JAMA. 2018 Apr 24;319(16):1687-1695. doi: 10.1001/jama.2018.3264. JAMA. 2018. PMID: 29710166 Free PMC article.
References
-
- Gilford H Ateleiosis and progeria: continuous youth and premature old age. BMJ. 1904;1904:914–918.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources